In the early morning of October 15th, Beijing time, the head of the media of the National Academy of Medicine replied to The Paper via email that Ming-Hui Zou was not an academician of the Academy.
Many scientific papers signed by Minghui Zou, a former professor at the University of Oklahoma Health Science Center and now a professor at the Center for Molecular and Translational Medicine at Georgia State University, have been withdrawn in recent years. Withdrawn on October 1, 2022. However, the "Academician of the American Academy of Medical Sciences" mentioned by some universities in China when they introduced Zou Minghui was not true after verification.
The international academic journal "American Journal of Physiology-Endocrinology and Metabolism" (American Journal of Physiology-Endocrinology and Metabolism) issued a retraction note on October 1, 2022, stating that at the request of the Office of Research Integrity at the University of Oklahoma Health Sciences Center , the American Physiological Society retracted a published paper. The reason is that the images of Figure 1 and Figure 2 in the paper are repeated, which seriously affects the experimental results and conclusions reported in the paper.
Paper retracted on October 1, 2022. Zou Minghui is one of the signed authors.
The title of the paper is "Suppression of the mTORC1/STAT3/Notch1 pathway by activated AMPK prevents hepatic insulin resistance induced by excess" amino acids), published online December 3, 2013.
The signed authors of the paper are Hongliang Li, Jiyeon Lee, Chaoyong He, Ming-Hui Zou and Zhonglin Xie.
Zhonglin Xie is the corresponding author of the paper. The only author of the paper is the Division of Medicine, Division of Medicine, University of Oklahoma Health Sciences Center.
According to the official website of the University of Oklahoma School of Medicine, Dr. Minghui Zou is one of Zhonglin Xie's two mentors. Minghui Zou has published many papers on complications of diabetes, especially oxidation and nitrification, and received sufficient research funding. He has been working in the research division of the National Institutes of Health and is experienced in mentoring postdocs and junior researchers. His extensive experience in oxidation and AMPK research will provide great support and good advice for Zhonglin Xie's research projects.
According to the information released by the news website of Hubei University of Science and Technology (renamed Xianning University in 2012), Professor Zou Minghui is an alumnus of the school in the 1980s. Mainly engaged in the research of vascular biology and pharmacology; now he is an "Academician of the American Academy of Medical Sciences"; in 2008, after being reviewed and officially approved by the Hubei Provincial Department of Education, Zou Minghui was appointed as a Distinguished Professor of the "Chutian Scholars Program" of Hubei University of Science and Technology. Discipline - Pharmacology Learning from Chutian Scholar Chair Professor; on the morning of September 19, 2008, the school held a relevant appointment ceremony.
According to the information released on the official website of the School of Pharmacy of Nanjing Medical University on July 1, 2020, Zou Minghui is the "Vice President" in charge of scientific research at Georgia State University, the director of the Center for Molecular and Translational Medicine, and a tenured professor of biomedicine. Academician of the Academy of Sciences".
Professor Zou Minghui returned to China to give lectures in 2015. Image source: Screenshot of the website of Hubei University of Science and Technology
On October 14, 2022, the reporter checked the official website of Georgia State University, and the school's management team - the president and vice president - did not include Zou Minghui in the list.
In addition, no information about Ming-Hui Zou was retrieved from the official website of the National Academy of Medicine.
In the early morning of October 15th, Beijing time, the head of the media of the National Academy of Medicine replied to The Paper via email that Ming-Hui Zou was not an academician of the Academy.
According to the relevant webpage of Georgia State University, in 2008, Minghui Zou was elected as a member of the American Society for Clinical Research.
According to public information, a number of papers for which Zou Minghui was the corresponding author or co-author have been withdrawn, and so far there have been 15 papers.
The 14 papers that have been retracted previously are:
1. On June 28, 2021, the international academic journal "Diabetes" published a retraction note online, stating that the University of Oklahoma Health Science Center requested the retraction of a paper by Minghui Zou as the corresponding author. The reason is that, after investigation by the center, many western blot images in the papers involved were forged.
The paper, published online on November 13, 2014, is titled "Myeloperoxidase Deletion Prevents High-Fat Diet–Induced Obesity and Insulin Resistance."
The signed authors of the paper are Qilong Wang, Zhonglin Xie, Wencheng Zhang, Jun Zhou, Yue Wu, Miao Zhang, Huaiping Zhu, and Ming-Hui Zou.
Minghui Zou is the corresponding author of the paper, whose signature unit is the Division of Internal Medicine, Department of Internal Medicine, University of Oklahoma Health Science Center.
Paper retracted on September 25, 2020. Minghui Zou is the corresponding author of the paper.
2. On September 25, 2020, Circulation, an international academic journal in the field of cardiovascular disease sponsored by the American College of Cardiology, published a retraction note online, stating that the author voluntarily requested to withdraw a paper, mainly because the Several Western blot images have been questioned for suspected image reuse and inappropriate modification; the editorial department asked the authors to provide relevant raw data, but they provided only some of the data. Although the first author admits that the data has been improperly altered, he stands by his experimental results. Out of an abundance of caution, the authors retract the paper.
The paper involved was published online on September 17, 2007, with the title "Hyperglycemia-induced reactive nitrogen inhibits Akt signaling and triggers apoptosis via LKB1-dependent upregulation of PTEN phosphatase" (Reactive Nitrogen Species). Induced by Hyperglycemia Suppresses Akt Signaling and Triggers Apoptosis by Upregulating Phosphatase PTEN (Phosphatase and Tensin Homologue Deleted on Chromosome 10) in an LKB1-Dependent Manner).
The signed authors of the paper are Ping Song, Yong Wu, Jian Xu, Zhonglin Xie, Yunzhou Dong, Miao Zhang and Ming-Hui Zou.
Minghui Zou is the corresponding author of the paper, whose signature unit is the Division of Endocrinology and Diabetes, Department of Medicine, University of Oklahoma Health Science Center.
3. On September 2, 2021, the international academic journal "Circulation Research" (Circulation Research) published a retraction note online saying that based on the findings of the University of Oklahoma Health Sciences Center, the editorial department of the journal retracted a paper. After investigation, many pictures in the paper were reused by the first author. He claims to have repeated the experiment and stands by his results and conclusions.
The title of the paper, "AMPKα2 Deletion Exacerbates Neointima Formation by Upregulating Skp2 in Vascular Smooth Muscle Cells," was published online on October 6, 2011.
Its named authors are Ping Song, Shuangxi Wang, Chaoyong He, Shaobin Wang, Bin Liang, Benoit Viollet, and Ming-Hui Zou.
Minghui Zou and Ping Song are the corresponding authors of the paper. Both are signed by the Department of Medicine, University of Oklahoma Health Sciences Center.
Paper retracted on December 6, 2019. Minghui Zou is the corresponding author of the paper.
4. On December 6, 2019, the international academic journal "Journal of Biological Chemistry" (JBC, Journal of Biological Chemistry) published a retraction statement online stating that, except for the unreachable author Bin Liang, the signed authors retracted a paper. Several images in the paper were suspected of being reused and were questioned. The authors claim that this is partly due to error. The authors stand by the data and conclusions in the paper.
The title of the paper is Activation of AMP-activated Protein Kinase α1 Alleviates Endothelial Cell Apoptosis by Activation of AMP-activated Protein Kinase α1 Alleviates Endothelial Cell Apoptosis by Increasing the Expression of Anti-apoptotic Proteins Bcl-2 and Survivin).
Its named authors are Chao Liu, Bin Liang, Qilong Wang, Jiliang Wu, and Ming-Hui Zou.
Minghui Zou is the corresponding author of the paper, whose signature unit is the Department of Medicine, University of Oklahoma Health Science Center.
5. On October 23, 2019, the international academic journal "Journal of Biochemistry" (JBC) published a retraction note online stating that the named authors retracted a paper. Several images in this paper are suspected of being reused. The authors claim that their experimental results have been confirmed by complementary experiments to the paper.
The title of the paper is "Activation of 5'-AMP-activated kinase during hypoxia-reoxygenation in bovine aortic endothelial cells is mediated by c-Src and phosphoinositide 3-kinase activity". AMP-activated Kinase Is Mediated through c-Src and Phosphoinositide 3-Kinase Activity during Hypoxia-Reoxygenation of Bovine Aortic Endothelial Cells), published online 24 June 2003.
Minghui Zou is the first author and corresponding author of the paper, whose signature unit is the Vascular Research Laboratory, Department of Surgery, University of Tennessee School of Medicine.
Paper retracted on August 9, 2019. Minghui Zou is the first author and corresponding author of the paper.
6. On August 9, 2019, the international academic journal "Journal of Biochemistry" (JBC) published a retraction note online stating that the named authors retracted a paper. Several images in this paper are suspected of being reused.
The title of the paper is "Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen" species), published online July 19, 2004.
Minghui Zou is the first author and corresponding author of the paper, whose signature unit is the Vascular Research Laboratory, Department of Surgery, University of Tennessee School of Medicine.
7. On June 10, 2019, the international academic journal "Journal of Biochemistry" (JBC) published a retraction note online stating that the named authors retracted a paper. The journal raises questions about Figures 1A, 4C, 5A and 8A, 8C of the paper. Twelve years after the paper was published, the authors were able to find some raw data, but not all. The authors stated that the experimental results of the paper have been confirmed by the supplementary experimental results in the paper.
The title of the paper is "Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase".
The signed authors of the paper are Yong Wu, Ping Song, Jian Xu, Miao Zhang and Ming-Hui Zou (Zou Minghui), which was published online on January 25, 2007.
Minghui Zou is the corresponding author of the paper, whose signature unit is the Division of Endocrinology and Diabetes, Department of Medicine, University of Oklahoma Health Science Center.
Paper retracted on December 6, 2019. Minghui Zou is the corresponding author of the paper.
8. On December 6, 2019, the international academic journal "Journal of Biochemistry" (JBCy) published a retraction note online saying that, except for Junhua Zhang, who could not be contacted, other signed authors retracted a paper. Several images in this paper are suspected of being reused. The authors claim that their experimental results have been confirmed by complementary experiments to the paper.
The title of the paper, "Identification of nitric oxide as an endogenous activator of the AMP-activated protein kinase in vascular endothelial cells," was published in 2008. Published online August 7.
The signed authors of the paper are Junhua Zhang, Zhonglin Xie, Yunzhou Dong, Shuangxi Wang, Chao Liu 1, Ming-Hui Zou (Zou Minghui).
Minghui Zou is the corresponding author of the paper, whose signature unit is the Division of Endocrinology and Diabetes, Department of Medicine, University of Oklahoma Health Science Center.
9. On December 6, 2019, the international academic journal "Journal of Biochemistry" (JBC) published a retraction statement online saying that except for Miao Zhang, Zhibo An, and Xuemei Geng who could not be reached, other signed authors retracted a paper. Several images in this paper are suspected of being reused.
The paper is titled "Nicotine-induced Activation of AMP-activated Protein Kinase Inhibits Fatty Acid Synthase in 3T3L1 Adipocytes," July 16, 2007 published online today.
The signed authors of the paper are Zhibo An, Hong Wang, Ping Song, Miao Zhang, Xuemei Geng, Ming-Hui Zou (Zou Minghui).
Minghui Zou is the corresponding author of the paper, whose signature units include the Division of Endocrinology and Diabetes, Department of Medicine, University of Oklahoma Health Sciences Center.
10. On August 14, 2019, the international academic journal "Journal of Biochemistry" (JBC) published a retraction note online stating that the named authors retracted a paper. Several images of the paper were suspected of being reused, and were questioned by the editorial department of the journal.
The title of the paper is "Protein kinase Czeta-dependent LKB1 serine 428 phosphorylation increases LKB1 nucleus export and apoptosis in endothelial cells". Published online March 5, 2008.
The signed authors of the paper are Ping Song, Zhonglin Xie, Yong Wu, Jian Xu, Yunzhou Dong, Ming-Hui Zou (Zou Minghui).
Minghui Zou is the corresponding author of the paper, whose signature unit is the Division of Endocrinology and Diabetes, Department of Medicine, University of Oklahoma Health Science Center.
11. On June 10, 2019, the international academic journal "Journal of Biochemistry" (JBC) published a retraction note online stating that the named authors retracted a paper. Multiple images in this paper are reused.
The paper is titled "Reactive Nitrogen Species Is Required for the Activation of the AMP-activated Protein Kinase by Statin in Vivo", online May 12, 2008 published.
The signed authors of the paper are Hyoung Chul Choi, Ping Song, Zhonglin Xie, Yong Wu, Jian Xu, Miao Zhang, Yunzhou Dong, Shuangxi Wang, Kai Lau, and Ming-Hui Zou.
Minghui Zou is the corresponding author of the paper, whose signature unit is the Division of Endocrinology and Diabetes, Department of Medicine, University of Oklahoma Health Science Center.
12. On August 14, 2019, the international academic journal "Journal of Biochemistry" (JBC) published a retraction note online stating that the named authors retracted a paper. The repeated use of multiple images in the paper was questioned by the editorial department of the journal.
The title of the paper is "Thromboxane A2 receptor activates a Rho-associated kinase/LKB1/PTEN pathway to attenuate endothelium insulin signaling". Published online April 29, 2009.
The signed authors of the paper are Ping Song, Miao Zhang, Shuangxi Wang, Jian Xu, Hyoung Chul Choi, Ming-Hui Zou (Zou Minghui).
Minghui Zou is the corresponding author of the paper, whose signature unit is the Division of Endocrinology and Diabetes, Department of Medicine, University of Oklahoma Health Science Center.
13. On January 25, 2021, the international academic journal "Journal of Molecular Endocrinology" published a retraction note online saying that at the request of the University of Oklahoma Health Sciences Center, the journal retracted a paper. The University of Oklahoma Health Science Center's investigation determined that Dr. Jun Zhou, the first author of the paper involved, deliberately forged multiple western blot images; a number of data were seriously falsified, rendering the scientific findings and conclusions of the paper invalid.
According to the retraction note, the journal editorial department was informed of the challenge in June 2019 and failed to resolve the issue after contacting the named author. In July 2019, the journal editorial department asked the University of Oklahoma Health Sciences Center to investigate the incident. The latter launched a covert investigation, which concluded in November 2020 that the manuscript should be retracted. On December 7, 2020, the journal editorial department received a retraction request from the University of Oklahoma Health Sciences Center.
The paper, titled "Hypochlorous acid via peroxynitrite activates protein kinase Cθ and insulin resistance in adipocytes", was published online in 2015.
The signed authors of the paper are Jun Zhou, Qilong Wang, Ye Ding, Ming-Hui Zou (Zou Minghui). Among them, Jun Zhou and Qilong Wang are the first authors.
Minghui Zou is the corresponding author of the paper, whose signature unit is the Division of Internal Medicine, Department of Internal Medicine, University of Oklahoma Health Science Center.
14. On May 19, 2020, the international academic journal "PLOS ONE" (PLOS ONE) published a retraction statement online saying that multiple images in a paper were suspected of being reused and were questioned. The authors claim that part of the original data was lost. They provided data from a partial replication of the experiment, but they were still unable to address the above questions. The editorial board of the journal decided to withdraw the paper. The named author Yong Wu disagrees with the retraction of the paper. Ping Song and Ming-Hui Zou agreed to retract the paper. Yunzhou Dong did not respond effectively.
The title of the paper is "Activation of the AMP-Activated Protein Kinase (AMPK) by Nitrated Lipids in Endothelial Cells", February 17, 2012 published online today.
The signed authors of the paper are Yong Wu, Yunzhou Dong, Ping Song and Ming-Hui Zou (Zou Minghui).
Minghui Zou is the corresponding author of the paper, whose signature unit is the Division of Internal Medicine, Department of Internal Medicine, University of Oklahoma Health Science Center.